Variant report

Variant	nsv1036208
Chromosome Location	chr13:38084093-38115110
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:37575595..37577181-chr13:38087888..38090592,2	K562	blood:
2	chr13:38102650..38103577-chr2:89203042..89203932,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EXOSC8-2	chr13:38109077-38109101	XLOC_010349
2	lnc-EXOSC8-2	chr13:38109952-38109988	XLOC_010349

Variant related genes	Relation type
ENSG00000120699	chromatin interactions

Extended variants
information (count: 912 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:912 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566451635	chr13:38084124-38084125	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs115888578	chr13:38084155-38084156	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs375354017	chr13:38084191-38084192	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs558564430	chr13:38084208-38084209	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs368132766	chr13:38084229-38084230	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs538384905	chr13:38084237-38084238	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs1358994	chr13:38084278-38084279	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs7326159	chr13:38084312-38084313	Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs557151992	chr13:38084352-38084353	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs575310186	chr13:38084485-38084486	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs560743516	chr13:38084507-38084508	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs536125261	chr13:38084512-38084513	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs186915928	chr13:38084604-38084605	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs78824821	chr13:38084609-38084610	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs191968182	chr13:38084620-38084621	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs540280746	chr13:38084644-38084645	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs183241814	chr13:38084748-38084749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs151184388	chr13:38084804-38084805	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs530428733	chr13:38084820-38084821	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs114777306	chr13:38084836-38084837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs573131096	chr13:38084879-38084880	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs560835867	chr13:38084880-38084881	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs139200574	chr13:38084883-38084884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs368830881	chr13:38084900-38084901	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs12865461	chr13:38084941-38084942	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs12865482	chr13:38084979-38084980	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs12866733	chr13:38084980-38084981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs79225362	chr13:38085082-38085083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs188305251	chr13:38085097-38085098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs545417194	chr13:38085121-38085122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs538591218	chr13:38085133-38085134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs192683960	chr13:38085139-38085140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs542124508	chr13:38085256-38085257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs563930696	chr13:38085266-38085267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs569262445	chr13:38085298-38085299	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs538385468	chr13:38085301-38085302	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs569190019	chr13:38085311-38085312	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs149949366	chr13:38085320-38085321	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs182490054	chr13:38085323-38085324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs374704610	chr13:38085361-38085362	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs555016885	chr13:38085413-38085414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs568594109	chr13:38085425-38085426	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs73180691	chr13:38085524-38085525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs9594219	chr13:38085537-38085538	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs577607463	chr13:38085555-38085556	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs570651585	chr13:38085556-38085557	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs546472319	chr13:38085581-38085582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs528561129	chr13:38085584-38085585	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs146426941	chr13:38085585-38085586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs543887001	chr13:38085683-38085684	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	18698080	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17899364	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Alveolar rhabdomyosarcoma	16790082	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Prostate cancer	21965145	CNVD
Hirschsprung''s Disease	21712996	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Monoclonal gammopathy of undetermined significance	19135901	CNVD
Prostate cancer	19242612	CNVD
Prostate cancer	17245344	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Developmental delay	21147756	CNVD
Colorectal cancer	21645411	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Melanoma	18172304	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:116 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:38083800-38084200	Enhancers	iPS-20b Cell Line	embryonic stem cell
2	chr13:38083800-38084400	Enhancers	iPS-15b Cell Line	embryonic stem cell
3	chr13:38083800-38084400	Enhancers	Osteobl	bone
4	chr13:38083800-38085200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr13:38083800-38085800	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr13:38084000-38084200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr13:38084000-38084200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr13:38084000-38084200	Flanking Active TSS	NHEK	skin
9	chr13:38084000-38084600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr13:38084200-38084400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr13:38084200-38084400	Active TSS	NHEK	skin
12	chr13:38084200-38084600	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr13:38084200-38084600	Enhancers	HMEC	breast
14	chr13:38084400-38084600	Flanking Active TSS	NHEK	skin
15	chr13:38084400-38088600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr13:38084600-38085600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr13:38084600-38085600	Enhancers	NHEK	skin
18	chr13:38085200-38085400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr13:38089400-38090000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr13:38089600-38090000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr13:38098400-38099000	Enhancers	NHDF-Ad	bronchial
22	chr13:38098600-38098800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr13:38098600-38099000	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr13:38098600-38099000	Enhancers	NHEK	skin
25	chr13:38098800-38100800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr13:38099000-38100200	Weak transcription	NHDF-Ad	bronchial
27	chr13:38100000-38100200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr13:38100000-38103800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr13:38100200-38101200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr13:38100200-38102400	Enhancers	NHDF-Ad	bronchial
31	chr13:38100400-38102600	Enhancers	Osteobl	bone
32	chr13:38100600-38101400	Enhancers	NHLF	lung
33	chr13:38100600-38102400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr13:38100800-38102000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr13:38101200-38102400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr13:38102000-38104000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr13:38102400-38105200	Weak transcription	NHDF-Ad	bronchial
38	chr13:38102600-38103400	Weak transcription	Osteobl	bone
39	chr13:38103400-38103600	Enhancers	Osteobl	bone
40	chr13:38103600-38104200	Weak transcription	Osteobl	bone
41	chr13:38103600-38104400	Enhancers	Fetal Muscle Leg	muscle
42	chr13:38103800-38104200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr13:38104000-38104400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr13:38104200-38104400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr13:38104200-38104400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr13:38104200-38104600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr13:38104200-38105000	Enhancers	Osteobl	bone
48	chr13:38104400-38105400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr13:38104400-38108400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr13:38104600-38105000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links